Hematopoietic SCT in Europe: Data and trends in 2011

Bone Marrow Transplantation

Volumn 48, Issue 9, 2013, Pages 1161-1167

  Passweg, J R ^a   Baldomero, H ^a   Bregni, M ^b   Cesaro, S ^c   Dreger, P ^d   Duarte, R F ^e   Falkenburg, J H F ^f   Kroger N ^g   Farge Bancel, D ^h   Bobby Gaspar, H ⁱ   Marsh, J ^j   Mohty, M ^k   Peters, C ^l   Sureda, A ^m   Velardi, A ⁿ   Ruiz De Elvira, C ^o   Madrigal, A ^p  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Paediatric Haematology Oncology   (Italy)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e HOSPITAL DURAN I REYNALS   (Spain)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k SORBONNE UNIVERSITÉ   (France)

^l ST ANNA CHILDREN S HOSPITAL   (Austria)

^m ADDENBROOKE S HOSPITAL   (United Kingdom)

ⁿ SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^o GUY S HOSPITAL   (United Kingdom)

^p ROYAL FREE HOSPITAL   (United Kingdom)

more..

Author keywords

Haematopoietic SCT; Indications; Reduced intensity conditioning; Transplant rates; Trends

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CONTROLLED STUDY; DONOR LYMPHOCYTE INFUSION; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HODGKIN DISEASE; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MISMATCH REPAIR; NONHODGKIN LYMPHOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SOLID TUMOR; TREATMENT INDICATION; UNRELATED DONORS;

EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY, 21ST CENTURY; HUMANS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84883741730     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.51     Document Type: Article

References (15)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
2. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472-1475.
3. Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010; 45: 219-234.
4. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617-1624.
5. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K et al. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant 2011; 46: 174-191.
6. Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 19918: 197-201.
7. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374-2386.
8. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Niederwieser D et al. Joint Accreditation Committee of the International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation; European Leukemia Net. Predictability of hematopoietic stem cell transplantation rates. Haematologica 2007; 92: 1679-1686.
9. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275-291.
10. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D et al. Changes in use of hematopoietic stem cell transplantation; a model for diffusion of medical technology. Haematologica 2010; 95: 637-643.
11. Martin I, Baldomero H, Bocelli-Tyndall C, Slaper-Cortenbach I, Passweg J, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng Part A 2011; 17: 2221-2230.
12. World Health Organisation, WHO (http://www.who.int/topics/ transplantation/en/).
13. Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012; 47: 906-923.
14. Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant 2010; 45: 811-818.
15. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628-1633.